Xenetic

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.

CEO

James F. Parslow

CEOJames F. Parslow

Employees

Employees2

Headquarters

Framingham, Massachusetts

HeadquartersFramingham, Massachusetts

Founded

2011

Founded2011

Employees

Employees2

XBIO Key Statistics

Market cap

4.12M

Market cap4.12M

Price-Earnings ratio

-1.04

Price-Earnings ratio-1.04

Dividend yield

—

Dividend yield—

Average volume

8.50K

Average volume8.50K

High today

$2.67

High today$2.67

Low today

$2.26

Low today$2.26

Open price

$2.40

Open price$2.40

Volume

7.10K

Volume7.10K

52 Week high

$5.20

52 Week high$5.20

52 Week low

$2.26

52 Week low$2.26

Xenetic

Why Robinhood?

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. Show more

XBIO Key Statistics

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.